Observations placeholder

Buprenorphine is a semisynthetic opioid derivative of thebaine. It is a mixed partial agonist opioid receptor modulator that is used to treat opioid addiction in higher dosages, to control moderate acute pain in non-opioid-tolerant individuals in lower dosages and to control moderate chronic pain in even smaller doses. It is available in a variety of formulations: Cizdol, Subutex, Suboxone, Zubsolv, Bunavail (available as buprenorphine HCl alone or buprenorphine and naloxone HCl; typically used for opioid addiction), Temgesic (sublingual tablets for moderate to severe pain), Buprenex (solutions for injection often used for acute pain in primary-care settings), Norspan and Butrans (transdermal preparations used for chronic pain)

On Oct, 16, 2015: 497 people reported to have side effects when taking Buprenorphine hydrochloride. Among them, 6 people (1.21%) have Hallucination.

Time on Buprenorphine hydrochloride when people have Hallucination  :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination100.00%0.00%0.00%0.00%0.00%0.00%0.00

On Oct, 16, 2015: 497 people reported to have side effects when taking Buprenorphine hydrochloride. Among them, 6 people (1.21%) have Death.